We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categori... Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States. Show more
false0000811240PRE 14A0000811240ecd:PeoMemberbiol:AdjustmentToCompensationFairValueIncreaseOrDecreaseFromPriorYearEndForAwardsThatVestedDuringTheYearMember2022-01-012022-12-310000811240ecd:NonPeoNe...
BIOLASE, INC false 0000811240 0000811240 2024-03-04 2024-03-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...
BIOLASE, INC false 0000811240 0000811240 2024-02-26 2024-02-26 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 BIOLASE, Inc. (Name of Issuer...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...
BIOLASE, INC false 0000811240 0000811240 2024-02-20 2024-02-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...
BIOLASE, INC false 0000811240 0000811240 2024-02-12 2024-02-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Biolase...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.043 | 29.0540540541 | 0.148 | 0.257 | 0.142 | 34451635 | 0.17595098 | CS |
4 | 0.051 | 36.4285714286 | 0.14 | 0.257 | 0.1251 | 11243715 | 0.16884892 | CS |
12 | -0.909 | -82.6363636364 | 1.1 | 1.14 | 0.1251 | 5391017 | 0.17121902 | CS |
26 | -1.679 | -89.7860962567 | 1.87 | 1.96 | 0.1251 | 2645857 | 0.23877367 | CS |
52 | -41.809 | -99.5452380952 | 42 | 47.1 | 0.1251 | 3745336 | 6.8998987 | CS |
156 | -87.349 | -99.7818140279 | 87.54 | 594 | 0.1251 | 2484747 | 37.10470611 | CS |
260 | -237.809 | -99.9197478992 | 238 | 594 | 0.1251 | 4072085 | 64.14912199 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions